Skip to main content
Universe Pharmaceuticals INC logo

Universe Pharmaceuticals INC — Investor Relations & Filings

Ticker · UPC ISIN · KYG9442G1047 US Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2024-11-01 Regulatory Filings
Country US United States of America
Listing US UPC

About Universe Pharmaceuticals INC

http://www.universe-pharmacy.com/

Universe Pharmaceuticals INC is a pharmaceutical company specializing in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine (TCM) derivative products. Through its subsidiaries, the company's product portfolio also includes biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about a Nasdaq notification regarding minimum bid price deficiency. The document is short (1476 characters) and does not contain detailed financial statements or substantive financial data. It is an announcement/report filed under the Securities Exchange Act of 1934, typical for foreign issuers to disclose material information. This type of filing is best classified under Regulatory Filings (RNS) as it does not fit into other specific categories like Annual Report, Earnings Release, or Interim Report.
2024-11-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Universe Pharmaceuticals INC, with the SEC. It announces a change of auditor from YCM CPA INC. to Enrome LLP, effective October 8, 2024. The document includes details about the auditor change, confirms no disagreements or reportable events with the former auditor, and references a letter from YCM CPA INC. This is a regulatory announcement about auditor change rather than a full audit report or annual report. The document length is 4694 characters, which is relatively short and focused on the auditor change event. Therefore, it fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not contain the full audit report or financial statements itself.
2024-10-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 6-K filed by Universe Pharmaceuticals INC, reporting the results of the 2024 Annual General Meeting (AGM). It details the voting outcomes on various proposals including director re-elections, share capital increase, share consolidation, and amendments to the memorandum of association. The content focuses on the official voting results from the AGM, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 7068 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, the appropriate classification is DVA.
2024-09-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by Universe Pharmaceuticals INC, reporting financial results for the six months ended March 31, 2024. It includes unaudited condensed interim consolidated financial statements and Management's Discussion and Analysis (MD&A). Form 6-K is used by foreign private issuers to report interim financial information and other material events. The presence of interim financial statements and MD&A indicates this is an Interim / Quarterly Report. The document is over 5,000 characters and contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2024-09-20 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a Current Report of a Foreign Private Issuer filed with the SEC. It specifically states it is furnishing documents related to the 2024 Annual General Meeting of Shareholders, including the Notice and Proxy Statement and the Proxy Card. The document itself does not contain the full AGM materials but announces their furnishing and provides exhibits related to the AGM. The document length is short (1765 characters), and it serves as a regulatory filing to announce the proxy materials for the AGM. According to the rules, such announcements are classified as Regulatory Filings (RNS) because it is not the full AGM materials themselves but a filing to furnish them.
2024-09-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, Universe Pharmaceuticals INC, reporting the closing of a public offering of ordinary shares. The content focuses on the completion of a capital raising event, specifying the number of shares offered, price per share, and total amount raised. There are no financial statements or detailed financial performance data included. The document is relatively short (2127 characters) and serves as an update on financing activity rather than a full financial report. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-07-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.